Old Web
English
Sign In
Acemap
>
authorDetail
>
Larry Lyons
Larry Lyons
Celgene
Nivolumab
Oncology
Medicine
Tolerability
Chemotherapy
2
Papers
30
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-Small Cell Lung Cancer
2019
Frontiers in Oncology
Jonathan W. Goldman
David M. Waterhouse
Ben George
Peter J. O’Dwyer
Rafia Bhore
Sibabrata Banerjee
Larry Lyons
Chrystal U. Louis
Teng Jin Ong
Karen Kelly
Show All
Source
Cite
Save
Citations (10)
Phase I study of nivolumab (Nivo) + nab-paclitaxel (nab-P) + gemcitabine (Gem) in advanced pancreatic cancer (APC).
2019
Journal of Clinical Oncology
Zev A. Wainberg
Howard S. Hochster
Edward J. Kim
Ben George
Aparna Kalyan
E. Gabriela Chiorean
David Waterhouse
Martin Gutierrez
Aparna Parikh
Rishi Jain
Daniel R. Carrizosa
Hatem Soliman
Rafia Bhore
Sibabrata Banerjee
Larry Lyons
Chrystal Ursula Louis
Teng Jin Ong
Peter J. O’Dwyer
Show All
Source
Cite
Save
Citations (20)
1